A. Houston

2.5k total citations
22 papers, 2.0k citations indexed

About

A. Houston is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, A. Houston has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Clinical Biochemistry. Recurrent topics in A. Houston's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (6 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). A. Houston is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (6 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). A. Houston collaborates with scholars based in United States, Brazil and Netherlands. A. Houston's co-authors include Michael A. Pfaller, R. J. Hollis, S. A. Messer, Ronald N. Jones, Bradley N. Doebbeling, Richard P. Wenzel, Gary V. Doern, Hélio S. Sader, Stacy L. Coffman and Ning Li and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Journal of Clinical Microbiology.

In The Last Decade

A. Houston

21 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Houston United States 17 1.5k 947 276 213 211 22 2.0k
C Kibbler United Kingdom 26 1.8k 1.2× 1.4k 1.4× 350 1.3× 195 0.9× 122 0.6× 39 2.5k
F Sánchez Spain 27 1.3k 0.9× 1.5k 1.5× 135 0.5× 167 0.8× 245 1.2× 83 2.5k
V. Krčméry Slovakia 25 1.8k 1.2× 1.6k 1.7× 266 1.0× 85 0.4× 228 1.1× 124 2.7k
Stacy L. Coffman United States 13 1.1k 0.7× 1.3k 1.3× 228 0.8× 91 0.4× 163 0.8× 18 1.9k
Jack D. Sobel United States 12 1.6k 1.0× 1.2k 1.3× 122 0.4× 128 0.6× 129 0.6× 21 2.0k
Élisabeth Chachaty France 23 773 0.5× 727 0.8× 199 0.7× 128 0.6× 373 1.8× 56 1.9k
Mark LaRocco United States 23 606 0.4× 770 0.8× 187 0.7× 250 1.2× 253 1.2× 61 1.9k
Thaís Guimarães Brazil 26 995 0.6× 928 1.0× 172 0.6× 146 0.7× 188 0.9× 96 2.1k
Eiman Mokaddas Kuwait 34 1.8k 1.2× 1.8k 1.9× 165 0.6× 108 0.5× 411 1.9× 112 2.7k
E. Geoffrey Playford Australia 31 1.6k 1.0× 1.6k 1.7× 163 0.6× 143 0.7× 141 0.7× 68 2.7k

Countries citing papers authored by A. Houston

Since Specialization
Citations

This map shows the geographic impact of A. Houston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Houston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Houston more than expected).

Fields of papers citing papers by A. Houston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Houston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Houston. The network helps show where A. Houston may publish in the future.

Co-authorship network of co-authors of A. Houston

This figure shows the co-authorship network connecting the top 25 collaborators of A. Houston. A scholar is included among the top collaborators of A. Houston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Houston. A. Houston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Houston, A., et al.. (2020). How has COVID‐19 impacted on Learning Disability Nursing Services in Scotland?. Journal of Psychiatric and Mental Health Nursing. 28(3). 503–504. 2 indexed citations
2.
Pfaller, Michael A., S. A. Messer, A. Houston, et al.. (2003). Characterization of Heteroresistance to Fluconazole among Clinical Isolates of Cryptococcus neoformans. Journal of Clinical Microbiology. 41(1). 267–272. 43 indexed citations
3.
Pfaller, Michael A., S. A. Messer, A. Houston, et al.. (2000). Evaluation of the Etest Method for Determining Voriconazole Susceptibilities of 312 Clinical Isolates of Candida Species by Using Three Different Agar Media. Journal of Clinical Microbiology. 38(10). 3715–3717. 41 indexed citations
4.
Pfaller, Michael A., et al.. (2000). In Vitro Activities of Ravuconazole (BMS-207147) against 541 Clinical Isolates of Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 44(10). 2883–2886. 60 indexed citations
5.
Pfaller, Michael A., Ronald N. Jones, Gary V. Doern, et al.. (1999). International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagnostic Microbiology and Infectious Disease. 35(1). 19–25. 213 indexed citations
6.
Perl, Trish M., et al.. (1999). Investigation of Suspected Nosocomial Clusters of Staphylococcus haemolyticus Infections. Infection Control and Hospital Epidemiology. 20(2). 128–131. 6 indexed citations
7.
Diekema, Daniel J., Michael A. Pfaller, S. A. Messer, et al.. (1999). In Vitro Activities of BMS-207147 against Over 600 Contemporary Clinical Bloodstream Isolates of Candida Species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. Antimicrobial Agents and Chemotherapy. 43(9). 2236–2239. 35 indexed citations
8.
Gales, Ana Cristina, Michael A. Pfaller, A. Houston, et al.. (1999). Identification of Candida dubliniensis Based on Temperature and Utilization of Xylose and α-Methyl- d -Glucoside as Determined with the API 20C AUX and Vitek YBC Systems. Journal of Clinical Microbiology. 37(12). 3804–3808. 89 indexed citations
9.
Pfaller, Michael A., S. A. Messer, A. Houston, et al.. (1998). National Epidemiology of Mycoses Survey: A Multicenter Study of Strain Variation and Antifungal Susceptibility Among Isolates of Candida Species. Diagnostic Microbiology and Infectious Disease. 31(1). 289–296. 117 indexed citations
10.
Pfaller, Michael A., et al.. (1996). Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. Journal of Clinical Microbiology. 34(1). 58–61. 221 indexed citations
11.
Edmond, Michael B., R. J. Hollis, A. Houston, & Richard P. Wenzel. (1995). Molecular epidemiology of an outbreak of meningococcal disease in a university community. Journal of Clinical Microbiology. 33(8). 2209–2211. 15 indexed citations
12.
Houston, A. & Ronald N. Jones. (1994). Post-Antibiotic Effect of FK-037 and Biapenem Tested against Five Bacterial Species. Journal of Chemotherapy. 6(1). 12–14. 2 indexed citations
13.
Rangel‐Frausto, M. Sigfrido, A. Houston, Martha J. Bale, Chun Fu, & Richard P. Wenzel. (1994). An experimental model for study ofCandida survival and transmission in human volunteers. European Journal of Clinical Microbiology & Infectious Diseases. 13(7). 590–595. 42 indexed citations
14.
Houston, A. & Ronald N. Jones. (1994). Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. Diagnostic Microbiology and Infectious Disease. 18(1). 57–59. 16 indexed citations
15.
Ena, Javier, A. Houston, Richard P. Wenzel, & Ronald N. Jones. (1993). Trends in Gram-Positive Bloodstream Organism Resistance: a Seven-Year Audit of Five Glycopeptides and Other Drugs at a Large University Hospital. Journal of Chemotherapy. 5(1). 17–21. 19 indexed citations
16.
Doebbeling, Bradley N., Gail Stanley, Michael A. Pfaller, et al.. (1992). Comparative Efficacy of Alternative Hand-Washing Agents in Reducing Nosocomial Infections in Intensive Care Units. New England Journal of Medicine. 327(2). 88–93. 376 indexed citations
17.
Widmer, Andreas F., et al.. (1992). A new standard for sterility testing for autoclaved surgical trays. Journal of Hospital Infection. 21(4). 253–260. 16 indexed citations
18.
Doebbeling, Bradley N., Gail Stanley, Michael A. Pfaller, et al.. (1992). Comparative Efficacy of Alternative Hand-Washing Agents in Reducing Nosocomial Infections in Intensive Care Units. Obstetrical & Gynecological Survey. 47(11). 789–790. 22 indexed citations
19.
Reagan, David R., Bradley N. Doebbeling, Michael A. Pfaller, et al.. (1991). Elimination of Coincident Staphylococcus aureus Nasal and Hand Carriage with Intranasal Application of Mupirocin Calcium Ointment. Annals of Internal Medicine. 114(2). 101–106. 273 indexed citations
20.
Pfaller, Michael A., Sérgio Barsanti Wey, Tim Gerarden, A. Houston, & Richard P. Wenzel. (1989). Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents. Diagnostic Microbiology and Infectious Disease. 12(1). 1–4. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026